Impel Pharmaceuticals (IMPL) null Earnings

16AugConfirmed
Mar 21
Apr 21
Q1 2021
Aug 21
-15.09
-10.06
-5.03
0

Details

Expected EPS
-0.6
Actual EPS
-1.1
Surprise EPS
-0.5
Surprise Percent
+83.33%

Description

Impel Pharmaceuticals (IMPL) has reported earnings of -1.1 per share for .

0 Comments

Share your thoughts